The absence of clinical hypogonadism and repeated observations of a low 1 7-ketosteroid excretion in gout, led Wolfson, Guterman, Levine, Cohn, Hunt, and Rosenberg (1949) and Wolfson (1954) to suggest that in this disease the adrenal cortex produces an abnormal androgen, which is not metabolized to 17-ketosteroids. Robinson, Conn, Block, Louis, and Katz (1949, 1952) also found a low ketosteroid excretion in gout, but Tarnopolsky, Montuori, and Schere (1950) and Butt and Marson (1952) , using a polarographic technique, were unable to confirm these results. Recently Zacco and Perrini (1955) fractionated the urinary 17-ketosteroids from a small series of eight patients and five controls; they found that the gouty patients excreted a smaller quantity of total 17-ketosteroids, and their data suggests an alteration in the ,3-ketosteroid and androsterone proportions. The previously published data are summarized in Table I .
Material and Methods
In the present investigation we have studied the excretion of total and of individual ketosteroids by nineteen male gout patients and seventeen normal males. In four cases, examinations were carried out during attacks of gout before and during treatment with colchicine.
Every patient, at some time, had had typical attacks and raised plasma uric acid levels, and none had any gross renal dysfunction. In all cases the total 17-ketosteroid excretion was estimated by two separate methods, and an aliquot of the total ketosteroid extract was then partitioned by chromatographic fractionation into eight parts.
For the purpose of comparing the mean values obtained, the 36 subjects were divided into two age groups:
(a) eight normal males and ten patients within the ages of 37-54 years; (b) an older group comprising nine normal males and nine patients within the ages of 54-76 years. Patients whose urines contained more than traces of protein were not included in this survey, since it has been shown by Beher and Gaebler (1951) that the 17-ketosteroids are not completely extracted from urines so contaminated. The ordinary tests for urinary protein were negative in seventeen of the patients, and barely positive in the remaining two.
As the constancy of the ketosteroid chromatographic pattern has been established for the normal male (e.g. Dobriner, 1953; Cook, Stitch, Hall, and Feldman, 1954; Johnsen, 1956a) , only single 24-hr urine specimens were collected from each normal control. A similar constancy for the gouty patient between attacks was established during this work, and consequently in twelve patients only single 24-hr urine extracts were fractionated, the other individual mean figures being the average of at-least two separate specimens.
The analytical methods employed are given in the Appendix.
Results Table II shows that we could find no significant difference in the mean values for creatinine and total 17-ketosteroids (estimated by two methods) between the controls and gouty patients in comparable age groups; the Table shows (28*7-57*0) (5*9-10*7)
In Table IV Wolfson (1954) has criticized the polarographic method employed by the latter authors, on the basis that "it is not a valid method of estimating 1 7-ketosteroid excretion as shown by its failure to show low values in gout patients". It is probable, however, that the technique is more specific than the many modifications of the colorimetric Zimmerman reaction (Barnett, Henly, and Morris, 1946) . Barnett, Henly, Morris, and Warren (1946) (1*10-7-69) (2 5-7-9) (1 68- 5 85 (1*314-13) (1 60-3-99) (0 43-1 08) Effect of Colchicine.-The 17-ketosteroid output of four of our patients was studied before and during an attack of gout treated with colchicine, but no significant or consistent changes were observed in either total steroid production or fractionation patterns. These findings confirm the previous work of Levine and Gregory (1951) and of Levine, Fred, and Bassett (1952) , who have shown that therapeutic doses of colcbicine have no effect upon the pituitaryadrenal axis of gouty patients or upon the 17-ketosteroid excretion of non-gouty patients. Robinson and others (1952) also found that colchicine had no effect on 17-ketosteroid excretion in the gouty patient.
Summary
(1) Determinations of the total and fractionated urinary neutral 17-ketosteroids have been carried out on nineteen men with gout and seventeen controls.
(2) No significant differences in total 17-ketosteroid excretion were observed between patients and controls of comparable ages, although the usual changes with increasing age were seen.
(3) There was a tendency for the younger gouty patient to excrete slightly less P-ketosteroids and androsterone than the younger controls, resulting in a slightly lower total 17-ketosteroid output. This trend, which was not statistically significant, was not found in the older patients.
(4) The duration of the disease appeared to have no effect upon the steroid fractionation pattern.
(5) Acute attacks of gout treated with colchicine caused no significant variation in total ketosteroid excretion or in the fractionation pattern, although slight erratic changes were seen. 
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